A cure and a bargain?
Caring for patients requires a successful business.
Update: ASHP statement released.
Programs increasingly cater to the uninsured and underinsured
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
While pharmacy benefit managers were grilled about insulin prices at Congressional hearings last week, some PBMs, insurers and pharma makers are already lowering insulin costs.
The real-world strategies used to manage the high cost of specialty meds.
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
Proposed HHS regulation would pass rebates on to consumers
Rounding up the news you need to know to start the new year.